MYELOMA
Clinical trials for MYELOMA explained in plain language.
Never miss a new study
Get alerted when new MYELOMA trials appear
Sign up with your email to follow new studies for MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new type of cell therapy for people with certain cancers (lymphoma, myeloma, and solid tumors like kidney cancer and sarcoma) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified …
Matched conditions: MYELOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New Five-Drug cocktail targets tough myeloma
Disease control Not yet recruitingThis study tests a new five-drug combination for people newly diagnosed with high-risk multiple myeloma. The goal is to see if adding two extra drugs (etentamig and isatuximab) to a standard three-drug regimen improves outcomes. About 220 participants will receive the combo befor…
Matched conditions: MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Real-World data to reveal how a leading myeloma combo works outside clinical trials
Knowledge-focused Not yet recruitingThis study will review medical records of 300 newly diagnosed multiple myeloma patients in the UK who cannot have a stem cell transplant and are treated with a three-drug combination (daratumumab, lenalidomide, and dexamethasone). The goal is to see how well the treatment works i…
Matched conditions: MYELOMA
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study looks at how to safely test for allergic reactions to biotherapy drugs in cancer patients. Researchers will find the highest skin test dose that does not cause irritation in most people. The goal is to create clear guidelines for doctors to diagnose allergies to these …
Matched conditions: MYELOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC